GL1X · GenesisL1 explorer

Research workbench

Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 ha trimer

Analyse Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6WXL
Type
protein
Length
2,175 residues
Chains
12
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hemagglutinin HA1 chain; Hemagglutinin HA2 chain; 1D12 light chain; 1D21 heavy chain
UniProt
A0A067Y6L0
Ligands
NAG
Pockets
20 · best druggability 0.82

Structure

electron microscopy · 4 distinct chains · 16% helix, 35% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, C, GHemagglutinin HA1 chainprotein3167% helix, 40% strandA0A067Y6L0
B, D, IHemagglutinin HA2 chainprotein17050% helix, 14% strandA0A067Y6L0
L, E, J1D12 light chainprotein1140% helix, 46% strand—
H, F, K1D21 heavy chainprotein1256% helix, 42% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 9 copies · chains A, L, B, D, I, E, C, J, G

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16610.820.8763empty
21830.810.9527empty
31770.800.9527empty
41810.800.9527empty
53550.750.8655empty

Interfaces

36 interfaces between chains.

  • I–G · 3161 Ų buried · 34 hydrogen bonds · protein-protein
  • A–B · 3149 Ų buried · 34 hydrogen bonds · protein-protein
  • D–C · 3144 Ų buried · 34 hydrogen bonds · protein-protein
  • B–D · 1278 Ų buried · 8 hydrogen bonds · protein-protein
  • D–I · 1274 Ų buried · 8 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 24 disulfide, 9 glycan (disulfide, N-glycosylation).

Compared structures

  • 6WXL · Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.